Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Jong-Youl Jin"'
Autor:
Keunchil Park, Jin-Soo Kim, Joo-Hang Kim, Young-Chul Kim, Hoon-Gu Kim, Eun Kyung Cho, Jong-Youl Jin, Miyoung Kim, Angela Märten, Jin-Hyoung Kang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Afatinib is approved globally for EGFR-TKI treatment-naïve patients with EGFR mutation-positive non-small cell lung cancer (NSCLC). In this Korean expanded access program, we evaluated its ‘real-world’ safety and efficacy. Me
Externí odkaz:
https://doaj.org/article/5eec3f88da44408eabe8ce0a99337a67
Autor:
Kwai Han Yoo, Jinhyun Cho, Boram Han, Se Hyung Kim, Dong-Yeop Shin, Junshik Hong, Hawk Kim, Hyo Jung Kim, Dae Young Zang, Sung-Soo Yoon, Jong-Youl Jin, Jae Hoon Lee, Dae-Sik Hong, Seong Kyu Park
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0235503 (2020)
PurposeWe evaluated the outcomes of decitabine as first-line treatment in older patients with acute myeloid leukemia (AML) and investigated the predictors, including a baseline mini nutritional assessment short form (MNA-SF) score, of response and su
Externí odkaz:
https://doaj.org/article/53b6687738da4aa0a2d6a91c173d5d54
Autor:
Der Sheng Sun, Yoon Ho Ko, Jong Youl Jin, In Sook Woo, Suk Young Park, Yun Ae Eom, Jin Hyoung Kang, Hoon Kyo Kim
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 3, Pp 406-416 (2023)
Background/Aims We compared the efficacy of the granisetron transdermal system (GTS) with that of ondansetron for controlling chemotherapy-induced nausea and vomiting (CINV) in patients treated with highly emetogenic chemotherapy (HEC). Methods We ra
Externí odkaz:
https://doaj.org/article/6cbaec29d6c3464081c63bf2848ce1b1
Autor:
Seo Ree Kim, Sang Hoon Chun, Jong Youl Jin, Tae-Geun Gweon, Hayemin Lee, Min-Sun Jin, Guk Jin Lee
Publikováno v:
Korean Journal of Clinical Oncology, Vol 17, Iss 2, Pp 126-130 (2021)
There have been several reports of complications of small bowel lymphoma, such as bleeding, obstruction, and perforation, often require emergency surgery. It is hardly showed complications of bleeding and wound dehiscence for diffuse large B cell lym
Externí odkaz:
https://doaj.org/article/620a6c03fb1b4e06a85beb86d6e6a570
Autor:
Guk Jin Lee, Hyunho Kim, Sung Shim Cho, Hyung Soon Park, Ho Jung An, In Sook Woo, Jae Ho Byun, Ji Hyung Hong, Yoon Ho Ko, Der Sheng Sun, Hye Sung Won, Jong Youl Jin, Ji Chan Park, In-Ho Kim, Sang Young Roh, Byoung Yong Shim
Background Oxaliplatin as part of XELOX regimen has a more favorable toxicity profile than cisplatin for patients with advanced gastric cancer (GC). However, oxaliplatin can induce sensory neuropathy, a cumulative, dose-related toxicity. Thus, capeci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2f9176dcdd45ccdbd0845f94a3af62d
https://doi.org/10.21203/rs.3.rs-1076759/v1
https://doi.org/10.21203/rs.3.rs-1076759/v1
Autor:
Guk Jin Lee, Hyunho Kim, Sung Shim Cho, Hyung Soon Park, Ho Jung An, In Sook Woo, Jae Ho Byun, Ji Hyung Hong, Yoon Ho Ko, Der Sheng Sun, Hye Sung Won, Jong Youl Jin, Ji Chan Park, In-Ho Kim, Sang Young Roh, Byoung Yong Shim
Publikováno v:
Journal of Gastric Cancer; Apr2023, Vol. 23 Issue 2, p315-327, 13p
Autor:
Jin-Hong Yoo, Seon Woong Choi, Sunghan Kim, Jong Youl Jin, Ik Seong Park, Jae Ki Choi, Seo Ree Kim, Seong Rim Kim, Hoon Kim
Publikováno v:
Journal of Korean Medical Science
Vaccination with an adenoviral vector vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can result in the rare development of thrombosis with thrombocytopenia mediated by platelet-activating antibodies against platelet fact
Autor:
Ji Hyun Gwak, Guk Jin Lee, Sang Hoon Chun, Seo Ree Kim, Mi Yeong Lee, Jong Youl Jin, Myoung Sim Kim
Publikováno v:
Palliativesupportive care. 19(5)
ObjectiveThe accurate estimation of expected survival in terminal cancer patients is important. The palliative performance scale (PPS) is an important factor in predicting survival of hospice patients. The purpose of this study was to examine how ini
Autor:
Jin Soo Kim, MI-Young Kim, Keunchil Park, Jong-Youl Jin, Joo Hang Kim, Hoon-Gu Kim, Jin-Hyoung Kang, Young-Chul Kim, Eun Kyung Cho, Angela Märten
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Background Afatinib is approved globally for EGFR-TKI treatment-naïve patients with EGFR mutation-positive non-small cell lung cancer (NSCLC). In this Korean expanded access program, we evaluated its ‘real-world’ safety and efficacy. Methods EGF
Autor:
Der Sheng Sun, Yoon Ho Ko, Jong Youl Jin, In Sook Woo, Suk Young Park, Yun Ae Eom, Jin Hyoung Kang, Hoon Kyo Kim
Publikováno v:
The Korean journal of internal medicine.
Background/Aims: We compared the efficacy of the granisetron transdermal system (GTS) with that of ondansetron for controlling chemotherapy-induced nausea and vomiting (CINV) in patients treated with highly emetogenic chemotherapy (HEC).Methods: We r